Dr. Garassino on Immunotherapy in EGFR-Mutated Lung Cancer – OncLive
OncLive |
Dr. Garassino on Immunotherapy in EGFR-Mutated Lung Cancer
OncLive Marina Chiara Garassino, MD, medical consultant in the Medical Oncology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, discusses immunotherapy for patients with EGFR-mutated lung cancer. Looking at the subgroup analysis for all … |
